Antioxidant, α-glucosidase inhibitory activity and sub-chronic toxicity of Derris reticulata extract: its antidiabetic potential

Abstract

BackgroundAntidiabetic activity of Derris reticulata extract on alloxan-induced diabetic rats has been reported. The extract was found to lower blood glucose and inhibit intestinal glucose absorption. The aim of this study was to further investigate mechanisms underlying the antihyperglycemic activity of D. reticulata extract in vitro.MethodsThe aqueous extract was obtained from D. reticulata stem. Phytochemical screening, total phenolic, and flavanoid contents were examined. ABTS and DPPH scavenging assays, and FRAP method were used to determine in vitro antioxidant activities. Measurement of cell viability on alloxan-induced cellular damage was performed in the insulin-secreting RINm5F cells by MTT assay. The effects of the extract on α-glucosidase activity and insulin release were studied. In addition, sub-chronic toxicity test in rats was also conducted.ResultsThe results revealed that the extract, which consisted of terpenoids, saponins, tannins and flavonoids, possessed moderate radical scavenging activities. Pre-treatment of RINm5F cells with the extract was also found to exert moderate, but significant, in vitro protection against alloxan, an oxidative stress producing agent. Unlike glibenclamide, the extract did not stimulate insulin secretion. However, the extract was found to inhibit α-glucosidase activity similar to acarbose. It was found that in sub-chronic toxicity studies D. reticulata extract did not cause mortality or produce any remarkable haematological, biochemical and histopathological adverse effects in rats.ConclusionsThe data suggest that the possible mechanisms underlying antihyperglycemic activity of D. reticulata extract are cytoprotective effect on pancreatic cells, presumably by its antioxidant activity, and inhibition of α-glucosidase. Sub-chronic toxicity study also provides scientific evidence to corroborate the safety of this plant as an alternative antidiabetic agent.

Antioxidant, antiglycation and insulinotrophic properties of Coccinia grandis (L.) in vitro: Possible role in prevention of diabetic complications

“…RINm5F cells (2 × 10 5 ) were incubated with CGF extract (Concentration: 0.0625 and 0.50 mg/mL) for 24 h. After the incubation period, the medium was removed. Cells were treated with alloxan at 9 mM (which caused about 50% of cell death) for 1 h 31 . At the end of experiment, cell viability was assessed by MTT assay as previously described 32 …”

<i>In Vitro</i> Evaluation of the Chemical Composition and Various Biological Activities of Ficus carica Leaf Extracts

“…Accordingly, researchers are looking for new potential antidiabetic agents from natural sources with less adverse effects. 9 Alzheimer's disease (AD) is the most common form of dementia, characterized by memory loss and other cognitive disabilities. Down-regulation of acetylcholine is associated with the development of AD.…”

Pharmacokinetics, toxicity, and cytochrome P450 modulatory activity of plumbagin

“…It is noted however that the ratios of plasma AST/ALT (>3:1) in both the control and treated rats were higher than the normal value reported in rats (2:1). Previous animal studies in Thailand using Wistar or Sprague Dawley rats (provided by the National Laboratory Animal Center of Thailand: NLACT) also reported the ratios of greater than 3:1 [26, 27]. Histopathological examination did not reveal any abnormality both in the control and treated groups.…”